Denmark
Novo Nordisk Foundation expands ambitious Challenge Programme internationallyÂ
April 30, 2025Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international
The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark
January 21, 2025Sales and Marketing CSL, Denmark, genetic, haemophilia, treatment
21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B …
Novo Nordisk invests 42bn Danish kroner to expand facilities in Kalundborg, Denmark
November 10, 2023Manufacturing and Production Chronic Diseases, Denmark, Novo Nordisk, investment, manufacturing
Novo Nordisk have announced plans to invest over 42bn Danish kroner to expand its existing manufacturing facilities in Kalundbord, Denmark, …
MHRA to extend EpiPen expiry dates to tackle shortages
October 18, 2018Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
Novo Nordisk cuts 650 roles around the world in R&D restructure
October 1, 2018Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma
Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Novo Nordisk to cut 2% of its entire workforce
September 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses
Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …
Novo Nordisk invests in new insulin-filling facility
November 4, 2015Manufacturing and Production Denmark, Novo Nordisk, manufacturing, production
Novo Nordisk is investing 2.1 billion Danish Kroner (about £200m) in a new facility in Hillerød, Denmark, which will produce diabetes …
Novo Nordisk expands in Denmark
September 8, 2015Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API
Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …
Novo Nordisk to open $130 million diabetes labs
November 3, 2014Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes
Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …
Novo Nordisk outlines hiring plans
June 12, 2014Sales and Marketing Denmark, Novo Nordisk, diabetes, haemostasis, pharma
Novo Nordisk has outlined ambitious plans for the medium-term, saying it will look to hire 6,000 staff in its native …
Danish government: ‘Sue pharma firms’
January 23, 2014Sales and Marketing Actavis, Danish, Denmark, Lundbeck, celexa
A senior figure in Denmark’s government has said that local authorities should take legal action against pharma firms which put …
Pronova gets EU nod for Omacor manufacturing plant
December 14, 2009Manufacturing and Production Denmark, Omacor, Pronova
Pronova BioPharma has been granted approval by EU regulatory authorities for its new manufacturing plant in Kalundborg, Denmark, that will …
Lilly to boost biotech stake in NeuroSearch deal
February 17, 2009Research and Development Denmark, Europe, NeuroSearch
Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
Danish court overturns Lipitor patent challenge
September 5, 2008Sales and Marketing Denmark, Lipitor, Pfizer, generics
A court in Denmark has ruled in favour of Pfizer in challenges to patents on the active ingredient – atorvastatin …
